Literature DB >> 17431037

Human prostate epithelium lacks Wee1A-mediated DNA damage-induced checkpoint enforcement.

Taija M Kiviharju-af Hällström1, Sari Jäämaa, Mia Mönkkönen, Karita Peltonen, Leif C Andersson, René H Medema, Donna M Peehl, Marikki Laiho.   

Abstract

Cellular DNA damage triggers the DNA damage response pathway and leads to enforcement of cell cycle checkpoints, which are essential for the maintenance of genomic integrity and are activated in early stages of tumorigenesis. A special feature of prostate cancer is its high incidence and multifocality. To address the functionality of DNA damage checkpoints in the prostate, we analyzed the responses of human primary prostate epithelial cells (HPECs) and freshly isolated human prostate tissues to gamma-irradiation. We find that gamma-irradiation activates the ataxia telangiectasia mutated-associated DNA damage response pathway in the HPECs but that the clearance of phosphorylated histone H2AX (gammaH2AX) foci is delayed. Surprisingly, gamma-irradiated HPECs were unable to enforce cell cycle checkpoint arrest and had sustained cyclin-dependent kinase 2 (Cdk2)-associated kinase activity because of a lack of inhibitory Cdk phosphorylation by Wee1A tyrosine kinase. We further show that HPECs express low levels of Wee1A and that ectopic Wee1A efficiently rescues the checkpoints. We recapitulate the absence of checkpoint responses in epithelium of ex vivo irradiated human prostate tissue despite robust induction of gammaH2AX. The findings show that prostate epithelium has a surprising inability to control checkpoint arrest, the lack of which may predispose to accrual of DNA lesions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17431037      PMCID: PMC1855358          DOI: 10.1073/pnas.0609299104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

Review 1.  Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment.

Authors:  Angelo M De Marzo; Theodore L DeWeese; Elizabeth A Platz; Alan K Meeker; Masashi Nakayama; Jonathan I Epstein; William B Isaacs; William G Nelson
Journal:  J Cell Biochem       Date:  2004-02-15       Impact factor: 4.429

2.  In vitro culturing and characteristics of transit amplifying epithelial cells from human prostate tissue.

Authors:  Aarti R Uzgare; Yi Xu; John T Isaacs
Journal:  J Cell Biochem       Date:  2004-01-01       Impact factor: 4.429

Review 3.  Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells.

Authors:  L Hartwell
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

Review 4.  Initiating cellular stress responses.

Authors:  Christopher J Bakkenist; Michael B Kastan
Journal:  Cell       Date:  2004-07-09       Impact factor: 41.582

Review 5.  Checking on DNA damage in S phase.

Authors:  Jiri Bartek; Claudia Lukas; Jiri Lukas
Journal:  Nat Rev Mol Cell Biol       Date:  2004-10       Impact factor: 94.444

6.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

7.  Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents.

Authors:  T Girinsky; C Koumenis; T G Graeber; D M Peehl; A J Giaccia
Journal:  Cancer Res       Date:  1995-09-01       Impact factor: 12.701

8.  Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase.

Authors:  L L Parker; H Piwnica-Worms
Journal:  Science       Date:  1992-09-25       Impact factor: 47.728

9.  Cell cycle regulation of human WEE1.

Authors:  C H McGowan; P Russell
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

10.  Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells.

Authors:  P Jin; Y Gu; D O Morgan
Journal:  J Cell Biol       Date:  1996-08       Impact factor: 10.539

View more
  33 in total

1.  Tissue slice grafts: an in vivo model of human prostate androgen signaling.

Authors:  Hongjuan Zhao; Rosalie Nolley; Zuxiong Chen; Donna M Peehl
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

2.  Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts.

Authors:  Xiaohua Ni; Yonggang Zhang; Judit Ribas; Wasim H Chowdhury; Mark Castanares; Zhewei Zhang; Marikki Laiho; Theodore L DeWeese; Shawn E Lupold
Journal:  J Clin Invest       Date:  2011-05-09       Impact factor: 14.808

3.  Cyclin-dependent kinase suppression by WEE1 kinase protects the genome through control of replication initiation and nucleotide consumption.

Authors:  Halfdan Beck; Viola Nähse-Kumpf; Marie Sofie Yoo Larsen; Karen A O'Hanlon; Sebastian Patzke; Christian Holmberg; Jakob Mejlvang; Anja Groth; Olaf Nielsen; Randi G Syljuåsen; Claus Storgaard Sørensen
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

4.  Differential epithelium DNA damage response to ATM and DNA-PK pathway inhibition in human prostate tissue culture.

Authors:  Zhewei Zhang; Zhiming Yang; Sari Jäämaa; Hester Liu; Laxmi G Pellakuru; Tsuyoshi Iwata; Taija M af Hällström; Angelo M De Marzo; Marikki Laiho
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

Review 5.  Addressing Patient Specificity in the Engineering of Tumor Models.

Authors:  Laura J Bray; Dietmar W Hutmacher; Nathalie Bock
Journal:  Front Bioeng Biotechnol       Date:  2019-09-12

6.  CRIF1 as a potential target to improve the radiosensitivity of osteosarcoma.

Authors:  Qian Ran; Feng Jin; Yang Xiang; Lixin Xiang; Qiushi Wang; Fengjie Li; Li Chen; Yuan Zhang; Chun Wu; Luping Zhou; Yanni Xiao; Lili Chen; Jiang Wu; Jiang F Zhong; Shengwen Calvin Li; Zhongjun Li
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

7.  Inhibition of Wee1, AKT, and CDK4 underlies the efficacy of the HSP90 inhibitor XL888 in an in vivo model of NRAS-mutant melanoma.

Authors:  H Eirik Haarberg; Kim H T Paraiso; Elizabeth Wood; Vito W Rebecca; Vernon K Sondak; John M Koomen; Keiran S M Smalley
Journal:  Mol Cancer Ther       Date:  2013-03-28       Impact factor: 6.261

8.  Metabolic reprogramming and validation of hyperpolarized 13C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor.

Authors:  Kayvan R Keshari; Renuka Sriram; Mark Van Criekinge; David M Wilson; Zhen J Wang; Daniel B Vigneron; Donna M Peehl; John Kurhanewicz
Journal:  Prostate       Date:  2013-03-26       Impact factor: 4.104

Review 9.  Molecular markers in prostate cancer. Part I: predicting lethality.

Authors:  Sachin Agrawal; William D Dunsmuir
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

10.  Identification of novel p53 pathway activating small-molecule compounds reveals unexpected similarities with known therapeutic agents.

Authors:  Karita Peltonen; Laureen Colis; Hester Liu; Sari Jäämaa; Henna M Moore; Juulia Enbäck; Pirjo Laakkonen; Anne Vaahtokari; Richard J Jones; Taija M af Hällström; Marikki Laiho
Journal:  PLoS One       Date:  2010-09-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.